KeyBanc maintained its Nike [NKE] rating to the equivalent of Overweight but changed the price target to $180.0 from $174, in a research note dated 2021-01-25. That figure represents around a 29.18% premium from where the company’s shares closed on Friday. Some new analysts also started their coverage, with KeyBanc Capital Markets’s analysts assigning the shares to “an Overweight” rating in a research note to investors issued in mid-December. Meanwhile, RBC Capital Mkts had launched its coverage on NKE with “an Outperform”, in a research note produced for clients on November 12, 2020. In addition, there was an upgrade from Deutsche Bank on September 23, 2020. The rater changed NKE from “a Hold” to “a Buy”.
Is NIKE Inc. [NYSE: NKE] a Good Buy Right Now?
It should be noted that NKE technical indicators for short, intermediate as well as long term progress have placed an overall average of 80% as Buy. The average signal changed from 88% Buy in the last week and compares with 100% Buy in the past month. Data from NIKE Inc.’s Trend Spotter indicated that the signals were Bearish. The stock current average is 4.26 million shares in the past 20 days and the short term average signal indicates a 50% Buy. In the last 50 days, the average trading volume was 5.59 million shares while the medium-term average advocated for 100% Buy. The average long-term signal stands at 100% Buy and the 100-day average volume stands at 6.17 million shares.
NKE Price Performance
On Wall Street, NIKE Inc. [NYSE:NKE] finished Friday’s session down -1.60% at $139.35. The stock went up to $141.88 at the same session while its lowest single-day price was $139.31. In the last five days, it saw a fall of about -1.38%, NIKE Inc. shares dropped by almost -1.50% since the beginning of the year. However, the share price has dropped to as low as -5.81% below its one year high. On 01/11/21, the company shares recorded $147.10, the highest single-day price it has got to in the last 52-weeks, and a 52-week low was seen on 01/04/21, the same year at $138.32. The company’s shares have inclined by 35.27% in the past year. The 50-day SMA achieved is $138.06 while the 200-day SMA is $113.77. Volume gained to 4.15 million from 4.01 million in the previous session.